Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.Methods We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.Results In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.Conclusions/interpretation Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, many studies have shown an increase in fatty acid oxidation and β-hydroxybutyrate in individuals with MASH compared to those without liver steatosis.,38,39 likely driven by the high fatty acid flux to the liver due to Adipo-IR.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citation
Cited by
Items 201–300 of 790
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 84
Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010024 · Cited by 76
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
Wang, R., Wang, L., Wu, H., Zhang, L., Hu, X., Li, C., & Liu, S. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111732 · Cited by 86
Hepatic insulin receptor: new views on the mechanisms of liver disease
Lee, W., Najjar, S. M., Kahn, C. R., & Hinds, T. D. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155607 · Cited by 79
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
Yoon, H., & Soo, B. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i11.800 · Cited by 83
Matafome, P. N., Louro, T. M., Rodrigues, L., Crisóstomo, J., Nunes, E., Amaral, C. P., Monteiro, P. F., Cipriano, A., & Seiça, R. M. F. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1157 · Cited by 81
Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
Edens, M. A., Kuipers, F., & Stolk, R. P. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00594.x · Cited by 81
Non-alcoholic fatty liver disease may develop in individuals with normal body mass index.
Margariti, E., Deutsch, M. J., Manolakopoulos, S., & Papatheodoridis, G. (2012) · PubMed Central · Cited by 86
Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities
Kanwal, A., Kanwar, N., Bharati, S., Srivastava, P., Singh, S. P., & Amar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020331 · Cited by 88
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging
Mashhood, A., Railkar, R., Yokoo, T., Levin, Y., Clark, L., Fox‐Bosetti, S., Middleton, M. S., Riek, J., Kauh, E., Dardzinski, B. J., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23928 · Cited by 74
Haga, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i46.12989 · Cited by 70
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
Chen, G., Ni, Y., Nagata, N., Xu, L., & Ota, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091379 · Cited by 83
Hajighasem, A., Farzanegi, P., & Mazaheri, Z. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1441872 · Cited by 76
Song, H., Zheng, Z., Wu, J., Lai, J., Chu, Q., & Zheng, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149670 · Cited by 100
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Heine, R. J., & Diamant, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02100.x · Cited by 75
Association between Serum Albumin, Insulin Resistance, and Incident Diabetes in Nondiabetic Subjects
Bae, J. C., Seo, S. H., Hur, K. Y., Kim, J. H., Lee, M., Lee, M. K., Lee, W., Rhee, E., & Oh, K. W. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.1.26 · Cited by 76
Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice
Shigiyama, F., Kumashiro, N., Tsuneoka, Y., Igarashi, H., Yoshikawa, F., Kakehi, S., Funato, H., & Hirose, T. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00072.2018 · Cited by 77
Armstrong, M. J., Hazlehurst, J. M., Hull, D., Guo, K., Borrows, S., Yu, J., Gough, S. C., Newsome, P. N., & Tomlinson, J. W. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12272 · Cited by 69
Ectopic fat: the true culprit linking obesity and cardiovascular disease?
Morelli, M., Gaggini, M., Daniele, G., Marraccini, P., Sicari, R., & Gastaldelli, A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0285 · Cited by 68
Self-citationHyperinsulinemia and the Development of Nonalcoholic Fatty Liver Disease in Nondiabetic Adults
Rhee, E., Lee, W., Cho, Y.-K., Kim, B.-I., & Sung, K. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.08.012 · Cited by 70
Valenti, L., Rametta, R., Ruscica, M., Dongiovanni, P., Steffani, L., Motta, B. M., Canavesi, E., Fracanzani, A. L., Mozzi, E., Roviaro, G., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-111 · Cited by 69
Sofer, E., Boaz, M., Matas, Z., Mashavi, M., & Shargorodsky, M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.01.011 · Cited by 73
Tang, Z., Sun, C., Yan, Y., Niu, Z., Li, Y., Xu, X., Zhang, J., Wu, Y., Li, Y., Wang, L., et al. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac061 · Cited by 71
Simental‐Mendía, L. E., Simental-Mendía, E., Rodríguez-Hernández, H., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2016) · PubMed · doi:10.5604/16652681.1212431 · Cited by 77
Mehmood, A., Zhao, L., Wang, Y., Pan, F., Hao, S., Zhang, H., Iftikhar, A., & Usman, M. A. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110180 · Cited by 71
A “systems medicine” approach to the study of non-alcoholic fatty liver disease
Petta, S., Valenti, L. V. C., Bugianesi, E., Targher, G., Bellentani, S., Bonino, F., Ferrannini, E., Loguercio, C., Lonardo, A., Marra, F., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.027 · Cited by 70
Self-citationLv, X., Dong, Y., Hu, L., Lu, F., Zhou, C., & Qin, S. (2020) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.163 · Cited by 65
Ke, F., Xue, G., Jiang, X., Li, F., Lai, X., Zhang, M., Shen, Y., & Gao, L. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155184 · Cited by 72
Tominaga, K., Fujimoto, E. K., Suzuki, K., Hayashi, M., Ichikawa, M., & Inaba, Y. (2009) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-008-0074-5 · Cited by 70
Fraser, A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Hepatology · doi:10.1002/hep.21667 · Cited by 72
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Inci, M. K., Park, S., Helsley, R. N., Attia, S. L., & Softic, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109224 · Cited by 69
A maternal high-fat diet is accompanied by alterations in the fetal primate metabolome
Cox, J. E., Williams, S., Grove, K. L., Lane, R. H., & Aagaard-Tillery, K. M. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.06.041 · Cited by 65
Chiang, C.-H., Huang, C., Chan, W., Chen, J., & Leu, H. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.09.003 · Cited by 65
Mey, J. T., Erickson, M. L., Axelrod, C. L., King, W. T., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2020 · Cited by 67
Bozkurt, L., Göbl, C. S., Tura, A., Chmelík, M., Prikoszovich, T., Kosi, L., Wagner, O. F., Roden, M., Pacini, G., Gastaldelli, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032710 · Cited by 63
Self-citationViewpoints on the Way to the Consensus Session
Iozzo, P. (2009) · Diabetes Care · doi:10.2337/dc09-s304 · Cited by 75
Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
Otten, J., Mellberg, C., Ryberg, M., Sandberg, S., Kullberg, J., Lindahl, B., Larsson, C. L., Hauksson, J. B., & Olsson, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.4 · Cited by 67
Association of ALT and the metabolic syndrome among Mexican children
Elizondo‐Montemayor, L., Ugalde‐Casas, P. A., Lam-Franco, L., Bustamante-Careaga, H., Gonzalez, M. S., Gutiérrez, N. G., & Martínez, U. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.08.191 · Cited by 66
Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.
Başaranoğlu, M., & Neuschwander‐Tetri, B. A. (2006) · PubMed · Cited by 96
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Self-citationDua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 72
Wang, X., Zhan, X., Li, X., Yu, J., & Liu, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17914 · Cited by 63
Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
Dallio, M., Diano, N., Masarone, M., Gravina, A. G., Patanè, V., Romeo, M., Di Sarno, R., Errico, S., Nicolucci, C., Abenavoli, L., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173134 · Cited by 56
Koehler, E., Swain, J., Sanderson, S., Krishnan, A., Watt, K., & Charlton, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02637.x · Cited by 60
NAFLD incidence and remission: Only a matter of weight gain and weight loss?
Marchesini, G., & Mazzotti, A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.023 · Cited by 61
Mucinski, J. M., Salvador, A. F., Moore, M. P., Fordham, T. M., Anderson, J. M., Shryack, G. E., Cunningham, R. P., Lastra, G., Gaballah, A. H., Diaz‐Arias, A. A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.017 · Cited by 66
Adipokines and Redox Signaling: Impact on Fatty Liver Disease
Parola, M., & Marra, F. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3848 · Cited by 60
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 61
Kwak, M., Kim, D., Chung, G. E., Kim, W., Kim, Y. J., & Yoon, J. (2015) · Liver International · doi:10.1111/liv.12552 · Cited by 58
Metabolic Syndrome as a Risk Factor for Nonalcoholic Fatty Liver Disease
Tsai, C.-H., Li, T., & Lin, C. (2008) · Southern Medical Journal · doi:10.1097/smj.0b013e31817e8af9 · Cited by 64
Cheng, F., Han, L., Xiao, Y., Pan, C., Li, Y., Ge, X., Zhang, Y., Yan, S., & Wang, M. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01253 · Cited by 59
Peng, L., Wu, S., Zhou, N., Zhu, S.-L., Liu, Q., & Li, X. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02595-2 · Cited by 60
Sao, R., & Aronow, W. S. (2018) · Archives of Medical Science · doi:10.5114/aoms.2017.68821 · Cited by 56
Hyperinsulinemic syndrome: The metabolic syndrome is broader than you think
Kelly, C. T., Mansoor, J., Dohm, G. L., Chapman, W. H. H., Pender, J. R., & Pories, W. J. (2014) · Surgery · doi:10.1016/j.surg.2014.04.028 · Cited by 66
The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
Perseghin, G. (2010) · Digestive Diseases · doi:10.1159/000282088 · Cited by 59
Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
Salomone, F., & Bugianesi, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.013 · Cited by 58
Self-citationWang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 58
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
Ferolla, S. M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.559 · Cited by 55
Bugianesi, E., Bizzarri, C., Rosso, C., Mosca, A., Panera, N., Veraldi, S., Dotta, A., Giannone, G., Raponi, M., Cappa, M., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.140 · Cited by 57
Self-citationMolecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
Rombouts, K., & Marra, F. (2010) · Digestive Diseases · doi:10.1159/000282094 · Cited by 54
Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte
Yang, J. S., Qi, W., Farias‐Pereira, R., Choi, S. H., Clark, J. M., Kim, D., & Park, Y. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.005 · Cited by 58
Gao, D., Jiao, J., Wang, Z., Huang, X., Ni, X., Fang, S., Zhou, Q., Zhu, X., Sun, L., Yang, Z. R., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.002 · Cited by 53
Huang, G. J., Wang, D., Zeb, I., Budoff, M. J., Harman, S. M., Miller, V. M., Brinton, E. A., Khoudary, S. R. E., Manson, J. E., Sowers, M. F., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.004 · Cited by 54
Khan, M. Y., Mihali, A. B., Rawala, M. S., Aslam, A., & Siddiqui, W. J. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001371 · Cited by 52
Viewpoints on the Way to a Consensus Session
Perseghin, G. (2009) · Diabetes Care · doi:10.2337/dc09-s303 · Cited by 52
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease
Valenti, L. V. C., Rametta, R., Dongiovanni, P., Motta, B. M., Canavesi, E., Pelusi, S., Pulixi, E. A., Fracanzani, A. L., & Fargion, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048804 · Cited by 51
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00019 · Cited by 46
Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
Hodson, L. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002653 · Cited by 55
Metabolic consequences of ENPP1 overexpression in adipose tissue
Pan, W., Ciociola, E., Saraf, M. K., Tumurbaatar, B., Tuvdendorj, D., Prasad, S., Chandalia, M., & Abate, N. I. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00087.2011 · Cited by 60
Ashworth, W. B., Davies, N. A., & Bogle, I. D. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005105 · Cited by 55
Kato, K., Takamura, T., Takeshita, Y., Ryu, Y., Misu, H., Ota, T., Tokuyama, K., Nagasaka, S., Matsuhisa, M., Matsui, O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092170 · Cited by 55
Willmes, D. M., Kurzbach, A., Henke, C., Schumann, T., Zahn, G., Heifetz, A., Jordan, J., Helfand, S. L., & Birkenfeld, A. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.003 · Cited by 51
Dai, L., Xu, J., Liu, B., Dang, Y., Wang, R., Zhuang, L., Li, D., Jiao, L., Wang, J., Zhang, L., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-021-0880-3 · Cited by 48
Liver fibrogenesis and metabolic factors
Anty, R., & Lemoine, M. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(11)70003-1 · Cited by 53
Insulin sparing action of Adenovirus 36 and its E4orf1 protein
Dhurandhar, N. V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.006 · Cited by 49
Margariti, A., Deutsch, M., Manolakopoulos, S., Tiniakos, D., & Papatheodoridis, G. V. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31826be328 · Cited by 47
Shargorodsky, M., Omelchenko, E., Matas, Z., Boaz, M., & Gavish, D. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-61 · Cited by 52
Dongiovanni, P., Rametta, R., Meroni, M., & Valenti, L. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110018 · Cited by 47
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., Targher, G., & Lonardo, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030355 · Cited by 50
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 51
Hughey, C. C., Puchalska, P., & Crawford, P. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159209 · Cited by 57
Lim, H.-W., & Bernstein, D. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.008 · Cited by 49
Choe, Y. G., Jin, W., Cho, Y. K., Chung, W. G., Kim, H. J., Jeon, W. K., & Kim, B. I. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12077 · Cited by 46
Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
Perseghin, G. (2011) · Diabetes Care · doi:10.2337/dc11-s249 · Cited by 43
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
Basu, R., Noureddin, M., & Clark, J. M. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.04.005 · Cited by 50
Post, A., Garcia, E., van den Berg, E. H., Flores-Guerrero, J. L., Gruppen, E. G., Groothof, D., Westenbrink, B. D., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13627 · Cited by 45
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes
Grønbæk, H., Thomsen, K. L., Rungby, J., Schmitz, O., & Vilstrup, H. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.5.705 · Cited by 50
Alcohol consumption and risk of fatty liver disease: a meta-analysis
Cao, G.-L., Yi, T., Liu, Q., Wang, M., & Tang, S. (2016) · PeerJ · doi:10.7717/peerj.2633 · Cited by 47
Independent tissue contributors to obesity-associated insulin resistance
Kusters, Y. H. A. M., Schalkwijk, C. G., Houben, A. J. H. M., Kooi, M. E., Lindeboom, L., Roodt, J. O. ’., Joris, P. J., Plat, J., Mensink, R. P., Barrett, E. J., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89695 · Cited by 44
Chen, Q., Zhou, X., Sun, Y., Fang, D., Zhao, Q., Huang, J., Jin, Y., & Wu, J.-S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5206 · Cited by 45
Yao, M., Qv, L., Lu, Y., Wang, B., Berglund, B., & Li, L. (2020) · Engineering · doi:10.1016/j.eng.2020.01.017 · Cited by 45
Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink
Chhimwal, J., Patial, V., & Padwad, Y. S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.04.011 · Cited by 51
Microbiota and nonalcoholic steatohepatitis
Imajo, K., Yoneda, M., Ogawa, Y., Wada, K., & Nakajima, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0404-6 · Cited by 45
Perez, M., Gonzáles, L., Olarte, R., Rodríguez, N. I., Tabares, M., Salazar, J. P., Jaimes, S., García, R. G., & López-Jaramillo, P. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2010.11.021 · Cited by 44
Petersen, K. F., Dufour, S., Mehal, W. Z., & Shulman, G. I. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.023 · Cited by 47
Green, C. J., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M.-E., & Hodson, L. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0038 · Cited by 37
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
Lin, Y., Wu, C.-C., & Ni, Y. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.603654 · Cited by 43
The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
Xu, H., & Wang, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.792667 · Cited by 43
Metadata
- Authors
- Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M.
- Affiliations
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Pisa (IT)
- Corresponding author
- Bugianesi, E.
- Venue
- Diabetologia
- Published
- 2005-03-04
- Volume
- 48
- Issue
- 4
- Pages
- 634-642
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1975388439
- Cited by
- 770
- References
- 63
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 42 · 2023: 48 · 2022: 47 · 2021: 48 · 2020: 51 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 49 · 2015: 37 · 2014: 40 · 2013: 35 · 2012: 32
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, glucose oxidation, hepatic glycogen synthesis, lipid oxidation, hepatic steatosis, adipose tissue, non-diabetic patients
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Body Composition, C-Peptide, Calorimetry, Indirect, Enzymes, Fasting, Fatty Acids, Nonesterified, Fatty Liver, Glucose, Glycerol, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, LDL, Liver, Male, Middle Aged, Oxidation-Reduction, Glucose Clamp Technique, 3-Hydroxybutyric Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.